Brian Levy - Net Worth and Insider Trading
Brian Levy Net Worth
The estimated net worth of Brian Levy is at least $91,500 dollars as of 2024-05-25. Brian Levy is the Chief Medical Officer of Aerie Pharmaceuticals Inc and owns about 6,000 shares of Aerie Pharmaceuticals Inc (AERI) stock worth over $91,500. Details can be seen in Brian Levy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Brian Levy has not made any transactions after 2013-10-30 and currently still holds the listed stock(s).
Transaction Summary of Brian Levy
Brian Levy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brian Levy owns 3 companies in total, including Ocata Therapeutics Inc (OCAT) , InSite Vision Inc (INSV) , and Aerie Pharmaceuticals Inc (AERI) .
Click here to see the complete history of Brian Levy’s form 4 insider trades.
Insider Ownership Summary of Brian Levy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OCAT | Ocata Therapeutics Inc | 2016-02-10 | director |
| INSV | InSite Vision Inc | 2015-11-02 | director |
| AERI | Aerie Pharmaceuticals Inc | 2013-10-30 | Chief Medical Officer |
Brian Levy Latest Holdings Summary
Brian Levy currently owns a total of 1 stock. Brian Levy owns 6,000 shares of Aerie Pharmaceuticals Inc (AERI) as of October 30, 2013, with a value of $91,500.
Latest Holdings of Brian Levy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AERI | Aerie Pharmaceuticals Inc | 2013-10-30 | 6,000 | 15.25 | 91,500 |
Holding Weightings of Brian Levy
Brian Levy Form 4 Trading Tracker
According to the SEC Form 4 filings, Brian Levy has made a total of 0 transactions in Aerie Pharmaceuticals Inc (AERI) over the past 5 years. The most-recent trade in Aerie Pharmaceuticals Inc is the acquisition of 6,000 shares on October 30, 2013, which cost Brian Levy around $60,000.
Insider Trading History of Brian Levy
- 1
Brian Levy Trading Performance
GuruFocus tracks the stock performance after each of Brian Levy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brian Levy is 72.21%. GuruFocus also compares Brian Levy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brian Levy within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Brian Levy's insider trading performs compared to the benchmark.
Performance of Brian Levy
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.17 | | | | | |
| Relative Return to S&P 500(%) | 5.76 | | | | | |
Brian Levy Ownership Network
Brian Levy Owned Company Details
What does Ocata Therapeutics Inc do?
Who are the key executives at Ocata Therapeutics Inc?
Brian Levy is the director of Ocata Therapeutics Inc. Other key executives at Ocata Therapeutics Inc include COO & CFO Edward H Myles , director & President and CEO Paul K Wotton , and SVP of Bus Development & CCO Jooste H Le Roux .
Ocata Therapeutics Inc (OCAT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Ocata Therapeutics Inc (OCAT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocata Therapeutics Inc (OCAT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Ocata Therapeutics Inc (OCAT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ocata Therapeutics Inc Insider Transactions
Brian Levy Mailing Address
Above is the net worth, insider trading, and ownership report for Brian Levy. Currently GuruFocus does not have mailing address information for Brian Levy.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
